OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Anna Orr

1 Projects | 1 Researchers | $135,000 Invested

2020

Weill Medical College of Cornell University

Anna Orr, PhD

Lead Optimization of Novel Site-Selective Blockers of Mitochondrial Complex III ROS as FTD Therapeutics

  • Funding Amount: $135,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Mitochondria/Metabolic Function
  • Status: Closed